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Economic decline, incarceration, and mortality from drug 
use disorders in the USA between 1983 and 2014: 
an observational analysis
Elias Nosrati, Jacob Kang-Brown, Michael Ash, Martin McKee, Michael Marmot, Lawrence P King
Summary
Background Drug use disorders are an increasing cause of disability and early death in the USA, with substantial 
geographical variation. We aimed to investigate the associations between economic decline, incarceration rates, and 
age-standardised mortality from drug use disorders at the county level in the USA.
Methods In this observational analysis, we examined age-standardised mortality data from the US National Vital 
Statistics System and the Institute for Health Metrics and Evaluation, household income data from the US Census 
Bureau, and county-level jail and prison incarceration data from the Vera Institute of Justice for 2640 US counties 
between 1983 and 2014. We also extracted data on county-level control variables from the US Census Bureau, the 
National Center for Health Statistics, and the US Centers for Disease Control and Prevention. We used a two-way 
fixed-effects panel regression to examine the association between reduced household income, incarceration, and 
mortality from drug use disorders within counties over time. To assess between-county variation, we used coarsened 
exact matching and a simulation-based modelling approach.
Findings After adjusting for key confounders, each 1 SD decrease in median household income was associated 
with an increase of 12·8% (95% CI 11·0–14·6; p<0·0001) in drug-related deaths within counties. Each 1 SD 
increase in jail and prison incarceration rates was associated with an increase of 1·5% (95% CI 1·0–2·0; p<0·0001) 
and 2·6% (2·1–3·1; p<0·0001) in drug-related mortality, respectively. The association between drug-related 
mortality and income and incarceration persisted after controlling for local opioid prescription rates. Our model 
accounts for a large proportion of within-county variation in mortality from drug use disorders (R²=0·975). 
Between counties, high rates of incarceration were associated with a more than 50% increase in drug-related 
deaths.
Interpretation Reduced household income and high incarceration rates are associated with poor health. The rapid 
expansion of the prison and jail population in the USA over the past four decades might have contributed to the 
increasing number of deaths from drug use disorders.
Funding None.
Copyright © 2019 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 
4.0 license.
Introduction
The USA has an ongoing epidemic of opioid addiction, 
with age-standardised mortality rates from drug use 
disorders increasing by more than 600% since 1980.1 
More than 72 000 overdose deaths occurred in 2017, 
making drug use disorders the second leading cause of 
death nationwide for people aged 15–49 years in the 
USA.1 The number of overdose deaths has increased in 
every county since 1980, but at considerably different 
rates, ranging from 8% to more than 8000%.1 Popular 
understanding of the unprecedented increase in 
overdose deaths focuses on the role of pharmaceutical 
companies in increasing the availability of opioid pain 
medication and, once addiction has been established, 
affected individuals substituting prescription opioids 
with heroin and fentanyl.2 Another body of research 
emphasises the increasing demand for drugs, driven by 
economic decline and downward social mobility.3,4 
However, this research remains inconclusive and does 
not explain the geographical variation in such deaths.1,5,6 
We argue that these two explanations, although valid, 
are incomplete and that incarceration represents 
another major driver of the epidemic in drug-related 
deaths. Extensive evidence has linked incarceration to 
various factors that are associated with drug overdoses, 
including stigma, unemployment, family disruption, 
and neighbourhood decline. In the USA, individuals are 
incarcerated in either state prison or local jail. In 2014, 
1 562 300 people were incarcerated in state and federal 
prisons, usually serving a sentence of 1 year or longer, 
whereas 744 600 people were incarcerated in local jails, 
most of whom were in pretrial detention. Although at 
any timepoint jails hold about half as many people as 
state prisons, in 2014, 11·4 million people were admitted 
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to jail, which is almost 20 times higher than the 
626 096 people admitted to prisons each year. 
More than half a million drug-related deaths have 
occurred in the USA in the past three and half decades, 
however, no studies have investigated the association 
between these deaths and the expansion of the 
incarcerated population, which began in the mid-1970s. 
In this analysis, we aimed to use previously unavailable 
panel data to examine the association between incar- 
ceration rates and drug-related deaths.
Methods
Data sources
We obtained age-standardised mortality data from 
1983–2014 from the US National Vital Statistics System and 
the Institute for Health Metrics and Evaluation using the 
Global Burden of Diseases, Injuries, and Risk Factors Study 
cause list (International Classification of Diseases [ICD], 
ninth edition diagnosis codes 292–292·9, 304·0–304·83, 
305, 305·1–305·93, 760·7–760·79, E850–850·29; ICD, 
tenth edition codes F11–F16·99, F18–F19·99, P04·4-P04·49, 
P96·1, R78·1–78·5).1 To measure local economic decline, 
we obtained median household income per county for the 
period 1983–2014 from the US Census Bureau.
We extracted county-level jail and prison incarceration 
data from the Vera Institute of Justice.7–10 The 
Vera Institute of Justice collected and compiled jail 
incarceration data from the Census of Jails11 and the 
Annual Survey of Jails12 by the Bureau of Justice Statistics 
to generate annual county-level rates per 100 000 residents 
aged 15–64 years. Prison data obtained from state 
corrections sources and the National Corrections 
Reporting Program of the Bureau of Justice Statistics 
was used by the Vera Institute of Justice to tabulate the 
county of origin of state prisoners, yielding annual 
county-level rates per 100 000 residents aged 15–64 years, 
with the earliest available data from 1983.9 Prison data at 
the state level are collected in the annual National 
Prisoner Statistics survey by the Bureau of Justice 
Statistics. We excluded six states (Alaska, Connecticut, 
Delaware, Hawaii, Rhode Island, and Vermont) because 
they do not have local jail systems. In these states, the 
prison system operates the pretrial detention and shorter 
sentences managed by county jails in other states. 
Thus, prison admissions data in those states are more 
comparable in magnitude to jail admissions data 
elsewhere, and the Bureau of Justice Statistics have not 
collected true prison admissions data in those states 
consistently. Due to discrepancies between data sources 
in measuring county boundaries and accounting for 
changes to counties over time, we excluded the state of 
Virginia and a number of counties from other states 
(77 counties in total) from the final analysis. Extreme 
outliers (ie, rates around 90 000 per 100 000 population), 
Research in context
Evidence before this study
The US opioid epidemic has been the subject of extensive 
scientific attention and debate, but little is known about the 
main causes. We searched PubMed, Science Direct, Scopus, 
Web of Science, and Google Scholar from database inception 
until Jan 1, 2019, using various combinations of the search 
terms “opioid(s)”, “overdose”, “drug-use disorders”, 
“substance abuse”, “deaths of despair”, “epidemic”, 
“crisis”, and “causes”. We also searched for terms such as 
“economic decline”, “inequality”, “poverty”, 
“unemployment”, and “disadvantage”, as well as 
“incarceration”, “imprisonment”, “penal state”, and “criminal 
justice”. We found that the public health and epidemiology 
literature focused on the supply of opioids and other drugs as 
determinants of the public health crisis in the USA, whereas 
economists and other social scientists highlighted social and 
economic factors such as unemployment, decline in income, 
and fractured family relations as determinants. 
However, few original empirical analyses have been done to 
investigate these determinants of the US opioid epidemic. 
Moreover, although a considerable body of literature has 
linked incarceration with drug use disorders, the emphasis 
is usually on drug use as the likely cause of incarceration, 
rather than incarceration as the cause of drug use disorders. 
To the best of our knowledge, no original empirical analyses 
have investigated the association between local jail and prison 
incarceration rates and mortality from drug use disorders at 
the county level.
Added value of this study
We empirically tested the associations between reduced 
household income (as a measure of economic decline), 
incarceration, and age-standardised mortality rates from 
drug use disorders between 1983 and 2014. We used previously 
unavailable jail and prison incarceration county-level panel 
data from the Vera Institute of Justice and mortality data from 
the US National Vital Statistics System. We confirmed the 
association between household income and drug-related 
deaths that has been hypothesised in the existing literature, 
and highlight a second and largely neglected determinant of 
the overdose epidemic—jail and prison incarceration 
rates—which together might be better predictors of overdose 
deaths than local opioid prescription rates alone. Our study 
adds to the scientific understanding of the public health crisis in 
the USA and could have major implications for public policy.
Implications of all the available evidence
Reduced household income and high incarceration rates show 
strong associations with mortality from drug use disorders. 
The rapid expansion of the US prison population since the 
1970s might have contributed substantially to the ongoing 
increase in overdose deaths.
For more on the US National 
Vital Statistics System see 
https://www.cdc.gov/nchs/nvss/
index.htm
For more on the Institute for 
Health Metrics and Evaluation 
see http://www.healthdata.org
For more on the US Census 
Bureau see https://www.census.
gov/
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potentially caused by measurement error in the Vera 
Institute of Justice dataset, were removed.
County-level control variables used to account for 
potential confounding were violent crime rate and 
the proportion of county residents who were African 
American, Hispanic, or other (non-white ethnicities). 
These variables were extracted from the US Census 
Bureau and the National Center for Health Statistics, 
with data derived from various census estimates, hence 
they are not available on an annual basis. To fill missing 
cells in the panel, linear interpolation was used to 
generate values between observations.13 As an additional 
control variable, we obtained county-level retail opioid 
prescription rates dispensed per 100 persons for the 
years 2006–14 from the US Centers for Disease Control 
and Prevention.
Data analysis
To examine the association between economic decline, 
incarceration, and deaths from substance abuse, we 
estimated a two-way fixed-effects panel regression, focused 
on within-county variation, thus controlling for any time-
invariant confounders. The fixed-effects model takes the 
natural logarithm of the mortality rate as the outcome, 
regressed on the median county household income and 
the county jail and prison admissions rates, controlling 
for education, crime rates, ethnicity, any time-invariant 
county-level confounders, and aggregate time trends 
using year dummies. As an additional sensitivity measure, 
we also controlled for all-cause mortality rates. All 
predictors were standardised by calculating deviations 
from the variable mean and dividing by 1 SD. To correct 
for the panel structure of the data, we estimated 
autocorrelation-consistent and heteroskedasticity-consistent 
SEs. R² was used to assess model performance. To assess 
model dependence, we also used a random-effects model 
(which pools within-county and between-county variation), 
a multilevel random intercept model (which allows between-
county variation in the intercept term), and a pooled 
ordinary least squares regression (which runs a conven-
tional ordinary least squares regression on a pooled set of 
county-years).
We also assessed variation between counties by 
specifying a ‘between’ model comparing counties with 
high versus low incarceration rates, controlling for other 
key characteristics. To reduce model uncertainty, we 
used coarsened exact matching.14–16 The aim of matching 
is to reduce inefficiency, bias, and model dependence. 
Matching aims to select units of analysis (counties) that are 
similar if not identical to one another in all respects except 
for one: whether or not they are exposed to a key variable of 
interest. In our analysis, the quantity of interest was the 
effect of high rates of incarceration on drug-related 
mortality, over and above the endogenous associations 
between incarceration and factors such as income, 
education, or crime. We therefore applied the algorithm to 
match counties that share all other key characteristics, but 
which differed in having high (above median) versus 
low (below median) incarceration rates. Counties were 
matched on the following time-averaged (1983–2014) 
variables: median household income, the proportion of 
high school graduates, African Americans, Hispanics, or 
other non-White ethnicity, the violent crime rate, and the 
opioid prescription rate (2006–14).
After extracting a pruned dataset from the matching 
procedure and running a between-county specification, 
we adopted a simulation-based approach to present 
key quantities of interest, as described by King and 
colleagues.17 This approach involves simulating numbers 
from the sampling distribution of our parameter 
estimates to account for model uncertainty. We then 
examined and visualised differences in the expected 
overdose mortality rate between counties with high and 
low incarceration rates, controlling for other factors. Let 
Ti ∈ {0, 1} denote a dichotomous treatment variable, 
where T=0 denotes counties with incarceration rates at 
1 SD below the global mean and T=1 designates counties 
at 1 SD above the global mean. Let Xi denote a series of 
pretreatment covariates (income, education, crime, drug 
environ ment, and ethnic composition). The simulations 
were done for T=0 and for T=1 separately before 
differences in the expected overdose mortality rate 
were examined. All statistical analyses were done using 
R (version 3.5.1), using the dplyr, ggplot2, plm, MatchIt, 
and Zelig software packages.
Role of the funding source
There was no funding source for this study.
Observed 
county-years, n
Mean (SD) Range
Age-standardised mortality rate 
from drug use disorders 
(per 100 000 population)
69 562 4·9 (4·7) 0·3–60·8
Jail admissions rate 
(per 100 000 population*)
67 172 7018·5 (3822·4) 20·2–18 445·2
Prison admissions rate 
(per 100 000 population*)
66 910 254·6 (160·3) 6·0–732·1
Median household income (US$) 69 562 46 841·9 (11 781·4) 17 582·8–125 704·6
High school graduates (proportion 
of county population)
69 562 0·8 (0·1) 0·3–1·0
Ethnicity (proportion of county population)
African American 69 562 0·1 (0·2) 0·0–0·9
Hispanic 69 562 0·1 (0·1) 0·0–1·0
Other 69 562 0·02 (0·05) 0·0–0·9
Violent crime rate 
(per 100 000 population)
61 367 284·8 (265·3) 0·0–3894·3
Opioid prescription rate 
(per 100 000 population)
20 049 90·7 (45·7) 0·0–437·2
Age-standardised all-cause 
mortality rate 
(per 100 000 population)
69 562 980·0 (138·4) 323·3–1716·8
All measures are at the county level. *Aged 15–64 years.
Table 1: Descriptive statistics
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Results
Our outcome variable was the annual age-standardised 
mortality rate from drug use disorders per 100 000 population 
for 2640 US counties between 1983 and 2014. Descriptive 
statistics are shown in table 1 and a correlation matrix is 
included in the appendix (p 1). The mortality rate from 
drug use disorders increased across counties between 
1980 and 2014 (figure 1), and between-county inequality 
in drug-related mortality also increased over time. 
Mortality rates were associated with economic hardship 
(figure 2), whereby low economic income was associated 
with a higher number of drug deaths; however, 
substantial heterogeneity was identified across counties 
with median incomes of less than US$60 000 per year.
Complete regression results from the fixed-effects 
model are shown in the appendix (p 2). The parameter 
estimates of the fixed-effects model suggest that both 
jail and prison incarceration rates are associated with 
elevated mortality rates from drug use disorders, while 
controlling for aforementioned control variables (table 2). 
An increase of 1 SD in admissions rates to local jail 
(mean 7018 [SE 3822] per 100 000 population) and prison 
(mean 254⋅6 [SD 160⋅3] per 100 000 population) was 
associated with a 1·5% (95% CI 1·0–2·0; p<0·0001) and 
a 2·6% (2·1–3·1; p<0·0001) increase in the mortality rate 
from drug use disorders, respectively. This suggests that 
high incarceration rates can compound the deleterious 
health effects of reduced median county household 
income, which is associated with a 12·8% (95% CI 
11·0–14·6; p<0·0001) increase in deaths from drug use 
disorders. Our model explained almost all of the within-
county variation in mortality rates (R²=0·975). Median 
household income and jail and prison rates alone account 
for almost all of this variation (R²=0·969).
The random-effects, multilevel random intercept, and 
pooled ordinary least squares regression models suggest 
that although the initial parameter estimates from the 
fixed-effects model are subject to some degree of model 
dependence, the substantive results remained the same 
(table 2). The estimates produced by the random-effects 
and multilevel random intercept models were almost 
identical to those produced by the fixed-effects model, 
whereas the estimates generated by the pooled ordinary 
least squares regression model were more variable.
When used as the sole regressor (adjusted for time 
trends), opioid prescription rates were associated with 
higher rates of mortality from drug use disorders 
(β=0·5%; 95% CI 0·2–0·8; p=0·02; appendix p 3). 
However, when controlling for income, incarceration, 
and crime, the estimated coefficient was not statistically 
significant. Thus, opioid prescription rates are not 
significantly associated with an increased mortality risk 
of drug use disorders when socioeconomic and 
incarceration variables are accounted for. In the full 
model including all covariates, we found that the 
parameter estimates for incarceration rates were reduced 
in size (by around one percentage point each), but 
remained statistically significant (appendix p 3). The 
statistical significance of our results was robust when 
controlling for all-cause mortality rates, suggesting that 
counties with high incarceration rates are not generically 
more deadly, but rather that they are more deadly in 
specific ways.
Figure 1: Drug deaths per 100 000 county residents, 1980–2014
Boxes show 50% of observations, lines show median, whiskers show IQR, 
and dots show individual counties.
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Figure 2: Drug deaths per 100 000 county residents by median household income, 1983–2014
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The matching algorithm resulted in a pruned dataset 
including 963 counties. The diagnostics confirmed that 
the matching procedure achieved a high degree of balance 
improvement, since the empirical covariate distributions 
in both the treatment and control groups were similar, 
meaning the reduced sample size strengthens rather 
than undermines the subsequent statistical inference. 
Hence, we estimated a between model using simple 
linear regression, where the outcome, Y, is regressed on 
the dichotomous treatment variable T.
As shown in figure 3A, the expected overdose mortality 
rate for counties in the control group was 3·5 deaths per 
100 000 county residents (95% CI 3·3–3·7; p<0·0001). The 
second density plot (figure 3B) showed that the treatment 
group had an estimated overdose rate of 5·4 deaths per 
100 000 county residents (95% CI 5·2–5·6; p<0·0001). As 
shown by the third and final density (figure 3C), these 
results suggest that, on average, high incarceration rates 
correspond to 1·9 excess deaths per 100 000 county 
residents (95% CI 1·5–2·2; p<0·0001), corresponding to a 
treatment effect equal to a 53⋅5% increase in the mortality 
rate from drug use disorders.
Discussion
Following a decline in prison incarceration rates in the 
1960s, the number of people held in state and federal 
prisons increased from less than 200 000 in 1970 to nearly 
1 million in 1995. Between 1972 and 2007, the prison and 
jail incarceration rate reached almost 800 incarcerations 
per 100 000 residents, which corresponds to more 
than 2·2 million incarcerated people.18,19 However, the 
incarcerated population accounts for only a quarter of 
individuals under correctional supervision when people 
on probation and parole are included. Thus, the overall 
correctional population has grown rapidly since 1972, 
amounting to 7 million individuals in 2012.18 Research 
has established that the rise in incarceration was not 
merely the result of increases in crime rates.19,20 Rather, it 
was primarily the result of a series of sentencing reforms 
that included mandatory sentences for drug convictions—
ie, so-called three strikes and truth in sentencing laws. 
These policies were established in response to a 
heightened focus on crime, reflected in the media and 
electoral campaigns—in which Democrat and Republican 
candidates competed to be tough on crime.21–23
Our findings suggest a strong association between the 
rise in incarceration rates and mortality rates from drug 
Fixed-effects model 
coefficient
Random-effects 
model
Multilevel random 
intercept model*
Pooled ordinary least 
squares model
Decline in household income 12·8%† (0·9) 13·1%† (0·9) 13·0%† (0·2) 1·5%‡ (1·0)
Jail admission rate per 100 000 population 1·5%† (0·3) 1·8%† (0·3) 1·7%† (0·1) 5·7%† (0·7)
Prison admission rate per 100 000 population 2·6%† (0·2) 2·9%† (0·2) 2·8%† (0·1) 8·2%† (0·7)
Observations, n 57 732 57 732 57 732 57 732
Adjusted R² 0·975 0·974 NA 0·808
Model coefficients are interpreted as percentage change in the drug-related mortality rate associated with a 1 SD increase in each predictor, for each of the four regression 
models specified. Panel-corrected SEs are given in parentheses. The model outcome variable was the natural logarithm of the age-standardised county mortality rate from 
drug use disorders. The model controls for county violent crime rate, the proportion of high school graduates, African American individuals, Hispanic individuals, and 
individuals of other ethnicities (non-white) in the county population, and aggregate time trends using year dummies (not shown). All predictors were standardised by 
calculating deviations from the variable mean and dividing by 1 SD. NA=not applicable. *Conventional SEs shown in parentheses. †p<0·0001. ‡p=0·141.
Table 2: Panel data models of county-level variation in mortality from drug use disorders
Figure 3: Estimated differences in county-level mortality rates from drug use 
disorders by incarceration rate
Expected overdose mortality rate by incarceration rate, where T=0 denotes 
counties with incarceration rates 1 SD below the global mean (A) and T=1 
denotes counties with incarceration rates 1 SD above the global mean (B), and 
expected difference in overdose mortality rate between countries with high and 
low levels of incarceration (C).
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use disorders, over and above the potential effects of low 
household income and other important confounders. 
We also highlight a largely neglected dimension of the 
US criminal justice system—local jails—which are 
independently associated with drug deaths. Our panel 
data showed regional inequalities over time and 
might contribute to the understanding of directionality 
of relevant associations that were identified in a previous 
cross-sectional study.24
Previous research has shown that mortality rates among 
former inmates are nearly 13 times higher than that of 
the general population, former inmates are at high risk of 
mortality during the first 2 weeks post release,25 and high 
incarceration rates exert cascading effects spanning 
generations, local communities, and other networks of 
current or former incarcerated people.18,19,21,22 Incarceration 
is directly associated with stigma, discrimination, poor 
mental health, and chronic economic hardship,18–20,26,27 all 
of which are linked to drug use disorders.28 Moreover, the 
interaction between substance abuse and incarceration 
interferes with treatment and reduces the likelihood of 
recovery.29–31 The incarceration of a family member has 
been shown to impair the wellbeing of non-incarcerated 
partners and children, as a result of declining household 
income, reduced parental investment, unstable social 
relationships, and psychosocial stress.26,27,32–37 A mother’s 
risk of a major depressive episode and her level of life 
dissatisfaction is heightened as a result of her partner’s 
incarceration.38 Children with an incarcerated parent are 
at increased risk of various health problems associated 
with adverse childhood experiences, including post-
traumatic stress disorder.34,35,38,39
Multiple pathways exist by which incarceration might 
lead to an increased number of drug deaths at the 
population level. A proposed set of mechanisms at the 
aggregate level is shown in figure 4. At the community 
level, the criminal justice system is pivotal in shaping 
the trajectories of neighbourhoods by removing prime 
working age men from their local communities, 
separating families, and disrupting social networks.18–20 
When coupled with economic hardship, the operations of 
the prison and jail systems constitute an upstream 
determinant of despair, whereby regular exposures to 
neighbourhood violence, unstable social and family 
relationships, and psychosocial stress trigger destructive 
behaviours.26,27,32–37 These are mechanisms that operate 
over and above the endogenous association between 
illegal drug use and incarceration, which does not account 
for the increased use of jails and prisons in recent 
decades.40 Since the rise in incarceration was primarily 
caused by statutory sentencing reforms in the USA, the 
so-called war on drugs itself seems to be an upstream 
determinant of the epidemic of drug-related mortality. 
Although policies that might reverse regional economic 
decline are likely to be both difficult and expensive to 
implement, reform of the criminal justice system is 
technically simple and would not only be economical, 
but could potentially save many lives. However, we 
acknowledge that such reform would face major political 
challenges, particularly from institutional forces that have 
a vested interest in increasing incarceration rates.
Our study had some limitations. Due to the 
observational nature of the study, we cannot rule out 
whether the observed associations can be explained by 
another factor that was unaccounted for. However, 
considerable unmeasured confounding would be needed 
to explain away our model estimates, which are adjusted 
for the most likely confounders in the context of the 
USA. Most notably, we found that incarceration rates 
were significantly associated with overdose deaths even 
after controlling for local opioid prescription rates since 
2006. This result does not preclude the possibility that 
the criminal justice system is located on the pathway 
leading from increased opioid prescription to heightened 
risk of mortality from overdoses, but it does indicate a 
robust connection between penal expansion and the 
current public health crisis in the USA. Moreover, 
existing research on the effects of incarceration on a 
range of social, economic, and health outcomes is 
consistent with our principal hypothesis that the 
combination of economic decline and incarceration is 
a likely driver of regional variation in drug-related 
mortality.19,26,27 A further limitation of our data is the 
distribution of missing values for county prison rates. 
Since the data did not meet the criteria for multiple 
imputation, we excluded around 15% of our observations 
using list-wise deletion of missing values, which could 
have skewed the sample away from Southern states 
where incarceration rates are the highest. Although our 
dataset does not include all states, it contains empirical 
data on jail and prison incarceration rates at the county 
level for the very first time. Our measurement of 
economic decline is at the aggregate level and would 
ideally be complemented by local employment data,6 
Figure 4: Schematic diagram of potential interactions between socioeconomic factors, incarceration, and 
drug-related mortality
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considering the link between de-industrialisation and 
health inequalities, which highlights the importance of 
the manufacturing sector.41
Our models do not explain the complex associations 
between overdose deaths and incarceration, or the 
heterogeneity that exists across the sexes and age groups. 
Moreover, we were unable to examine important state-
level differences in the quality of post-incarceration 
support offered to former inmates, which is an important 
predictor of health and employment outcomes.42 Our 
different model specifications yield results of differing 
magnitudes, but these pertain to differences in the 
distribution of variation within and between counties, 
and we consider these reasonable bounds on the 
magnitude of potential associations. Moreover, the 
fixed-effects, random-effects, and multi level random 
intercept models yielded similar parameter estimates. 
Our substantive findings are robust to alter native 
specifications, and our parsimonious models successfully 
capture a substantial amount of variation in our data. 
The matching algorithm helped to reduce model 
dependence and strongly indicates that incarceration is a 
driver of the spatial patterning of the ongoing overdose 
epidemic, over and above other associated factors.
The reasons for the substantial regional variation in 
drug-mortality rates need to be understood to enable the 
development of prevention and intervention strategies.1 
We have shown that incarceration might be an important 
upstream determinant of mortality from drug use 
disorders in the USA, beyond economic decline and local 
opioid prescription rates. Jails and prisons are associated 
with heightened mortality risk, not only for incarcerated 
individuals, but also for their relatives and the general 
population. Thus, the rapid expansion of the prison and 
jail population over the past few decades might have made 
a substantial contribution to the increasing number of 
deaths from drug use disorders. Future research and policy 
should focus on the impacts of incarceration, or more 
broadly, of punitive social policy, on population health.
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